Using CD96−/− mice, Chan et al. recently demonstrated that loss of CD96 expression resulted in improved tumor control of methylcholanthrene (MCA)-induced fibrosarcoma and lung metastasis (63). This evidence concerns the gene CD96 and neoplasm.